The nuclear medicine business is an important driver of higher margins for the drug distribution company. While just a small part of Cardinal Health's (NYSE: CAH) $100 billion-plus revenue, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback